Primary record
1-Piperazinebutanol, a-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-, hydrochloride (1:1);1-Piperazinebutanol, a-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-, hydrochloride (1:1)
- 库存
- 5,106 克
- 纯度
- 98.3 %
- CAS
- 105565-56-8
化合物标识与属性
- CAS
- 105565-56-8
- PubChem CID
- 108046
- SMILES
- C1CN(CCN1CCCC(C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F
- Canonical SMILES
- OC(CCCN1CCN(c2ncc(F)cn2)CC1)c1ccc(F)cc1
名称与同义词
- Bmy-14802
- Bmy 14802
- A5NB5G07JO
- bmy-14802 hydrochloride
- 105565-56-8
- GTPL8
- RefChem:120802
- CHEMBL60859
- D01YOC
- UNII-A5NB5G07JO
- Bms 181100
- BMS-181100
- BMY-14802, Skybridge
- alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol
- SCHEMBL467229
- BMY-14802-1 Free
- DTXSID70909596
- ZXUYYZPJUGQHLQ-UHFFFAOYSA-N
- AC1L338H
- orb1685601
- Bmy-14786
- C18H22F2N4O
- CHEBI:91549
- Bmy 14802-1
- BMY14802
- BDBM50002238
- C18-H22-F2-N4-O
- CID108046
- PDSP1_000017
- PDSP2_000017
- BMY-14802 (dyskinesia), Skybridge
- CID:108046
- ( -)-BMS 14802
- (+-)-BMS 14802
- BMY-14802-1
- (A+-)-BMY-14802
- 1-(4-fluorophenyl)-4-[4-(5-fluoropyrimidin-2-yl)piperazin-1-yl]butan-1-ol
- DA-50350
- MJ-14676
- MJ-14786
- MJ-14802
- MS-25366
- (+)-BMY-14802
- (-)-BMY-14802
- SID:134224547
- HY-153091
- J227.825A
- J292.257F
- J292.933C
- LS-186843
- LS-187505
- (+/-)-BMY-14802
- CS-0650370
- BMY-14802, >=97% (HPLC)
- H37191
- 5-HT 1a receptor agonist (dyskinesia), Skybridge
- C050408
- L023990
- 1-(4-fluorophenyl)-4-(4-(5-fluoropyrimidin-2-yl)piperazin-1-yl)butan-1-ol
- Q4836101
- BRD-A15435692-003-01-5
- BRD-A15435692-003-02-3
- 1-Piperazinebutanol, alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-
- alpha-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazinebutanol
- 1-(4-Fluoro-phenyl)-4-[4-(4-fluoro-phenyl)-piperazin-1-yl]-butan-1-ol
- 105565-55-7
- 4-[4-(5-fluoro-2-pyrimidinyl)-1-piperazinyl]-1-(4-fluorophenyl)butanol
- alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine-1-butanol
- (+)-alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine-1-butanol
- (-)-alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine-1-butanol
- (R)1-(4-Fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol
- (S)1-(4-Fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol
- .ALPHA.-(4-FLUOROPHENYL)-4-(5-FLUORO-2-PYRIMIDINYL)-1-PIPERAZINEBUTANOL
- 1-(4-Fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol
- 1-(4-fluorophenyl)-4-(4-(5-fluoro-2-pyrimidinyl)-1-piperazinyl)-1-butanol
- 1-[4-(4-fluorophenyl)-4-hydroxybutyl]-4-(5-fluoropyrimidin-2-yl)-piperazine
- 1-PIPERAZINEBUTANOL, .ALPHA.-(4-FLUOROPHENYL)-4-(5-FLUORO-2-PYRIMIDINYL)-
- 4-{4-[5-Fluoro-2-(4-fluoro-phenyl)-2H-pyrimidin-1-yl]-piperazin-1-yl}-butan-1-ol
- 1-(4-Fluoro-phenyl)-1-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol(BMY-14802)
- 1-(4-Fluoro-phenyl)-4-[4-(5-fluoro-pyrimidin-2-yl)-piperazin-1-yl]-butan-1-ol(BMY-14802)
- 1-Piperazinebutanol, a-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-, hydrochloride (1:1);1-Piperazinebutanol, a-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-, hydrochloride (1:1)
- 4-{4-[5-Fluoro-2-(4-fluoro-phenyl)-2H-pyrimidin-1-yl]-piperazin-1-yl}-butan-1-ol(BMY 14802)